Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARTIVION, INC.AORT · Entity 4767 | Director | May 18, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARTIVION, INC.
Report date May 18, 2026 · Filed May 21, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,664 |
Reported balance
After 2026-05-18 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-18 · Grant · Acquired 7,576 · Balance 56,664 F1: This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment. F2: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment.
F2: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2026 Filed May 21, 2026 01:15 UTC Amendment | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 7,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-037028 · wk-form4a_1779326110.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,664 F1 · date: This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment. F1 · shares: This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment. F2 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan. F1 · balance_after: This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment. Read SEC document |
| May 14, 2026 Filed May 20, 2026 01:59 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 7,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-036713 · wk-form4_1779242386.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,938 F1 · shares: RSA Grant vests on May 14, 2027, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:19 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 6,325 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-25-000115 · wk-form4_1748377189.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,088 F1 · shares: RSA Grant vests on May 22, 2026, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:29 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000193 · wk-form4_1717417776.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,763 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:55 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 9,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-23-000116 · wk-form4_1686261348.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,474 F1 · balance_after: RSA Grant vests on June 6th 2024, pursuant to the terms of the Equity and Cash Incentive Plan? Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:36 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 7,878 | $19.04 | $149,997.12 |
DisclosureSEC source: 0000784199-22-000141 · certent-form4.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,765 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2023, provided the status as a Director with Artivion continues through such date. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:21 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000167 · certent-form4.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,887 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:42 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000157 · certent-form4.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,464 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:16 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 1,178 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000103 · certent-form4.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,797 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 16, 2019 Filed May 17, 2019 20:20 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,163 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000112 · certent-form4.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,619 F1 · shares: Represents shares of restricted stock that cliff vest on May 16, 2020, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| August 09, 2018 Filed Aug 15, 2018 21:47 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 3,456 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000171 · certent-form4.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,456 F1 · shares: Represents shares of restricted stock that cliff vest on August 9, 2019, provided the status as a Director with CryoLife continues through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.